Skip to main content
SpringerLink
Log in

Fixed Combination Drug Therapy

  • Review Articles
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Almost half of all marketed drugs are fixed combination preparations, yet the World Health Organization included only 7 in its list of 240 ‘essential’ drugs. There has been little scientific study of these preparations but much emotion and rhetoric has been expended both for and against them.

Potential advantages of fixed combination preparations include: increased compliance, synergy and increased efficacy, and reduced side effects and cost. Potential disadvantages include: inflexible fixed dose ratio, incompatible pharmacokinetics, increased toxicity, and physician and pharmacist ignorance of content.

There are a few combinations of undisputed value such as oral contraceptives, levodopa with decarboxylase inhibitors, and pyrimethamine with sulphadoxine. In other cases fixed- dose combinations may have value in strictly specified circumstances, but are probably overprescribed. There is also widespread, unjustified use of combinations in over-the-counter preparations which may have unrecognised adverse effects. Combinations should only be used if each component is necessary for the desired effect and if the advantages outweigh the added risks of using 2 or more drugs. Before prescribing combination drugs, clinicians should always ask themselves a series of questions of which the most important is whether the patient needs each drug in a particular combination, or if I component alone would be adequate.

In general, government regulatory bodies in ‘developed’ countries are attempting to curb the use of combination drugs, but a more profitable approach might be to better educate doctors on both the advantages and disadvantages of fixed combination preparations leading to improved prescribing habits.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abel, R. and Leopold, I.H.: Ocular diseases; in Avery (Ed) Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics 2nd ed., pp.371–377 (ADIS Press, Sydney and New York 1980).

    Google Scholar 

  • Arnold, K.: Trends in the development of chemotherapy for parasitic diseases. Southeast Asian Journal of Tropical Medicine and Public Health 9: 177–182 (1978).

    PubMed  CAS  Google Scholar 

  • Ayd, F.J.: Single daily dose of antidepressants. Journal of the American Medical Association 230: 263–264 (1974).

    Article  PubMed  Google Scholar 

  • Bank, S.; Saunders, S.J.; Marks, I.N.; Novis, B.N. and Barbezat, G.O.: Gastrointestinal and hepatic diseases; in Avery (Ed) Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics, 2nd ed., p.713 (ADIS Press, Sydney and New York 1980).

    Google Scholar 

  • Barclay, I.; Whiting, B.; Meredith, P.A. and Addis, G.J.: Theophylline-salbutamol interaction: Bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. British Journal of Clinical Pharmacology 11: 203–208 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Beaver, W.T.: Analgesic combinations; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp.52–72 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Beeley, L.: When do patients on diuretics need potassium replacement? Adverse Drug Reaction Bulletin 84: 304–307 (1980).

    Article  Google Scholar 

  • Beutler, E. and Meerkreebs, G.: Doses and Dosing. New England Journal of Medicine 274: 1152–1153 (1966).

    Google Scholar 

  • Biron, P.: A hopefully based pilot survey of physicians’ knowledge of the content of drug combinations. Canadian Medical Association Journal 109: 35–39 (1973).

    PubMed  Google Scholar 

  • British National Formulary: Drugs acting on the Gastrointestinal System; in British National Formulary Number 1, P-29. British Medical Association and the Pharmaceutical Society of Great Britain (1981).

    Google Scholar 

  • Brogden, R.N.; Carmine, A.A.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Trimethoprim: A review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs 23: 405–430 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Brumfitt, W. and Pursell, R.: Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in the treatment of urinary infection. British Medical Journal 2: 673–676 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Budd, J.H.: Combination drugs in medical practice; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 46–51 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Chisholm, M.: A controlled clinical trial of prophylactic folic acid and iron in pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth 73: 191–196 (1966).

    Article  Google Scholar 

  • Chrai, S.S.; Makoid, M.C.; Eriksen, S.P. and Robinson, S.R.: Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. Journal of Pharmaceutical Science 63: 333–338 (1974).

    Article  CAS  Google Scholar 

  • Clark, G.M. and Troop, R.C.: One tablet combination drug therapy in the treatment of hypertension. Journal of Chronic Diseases 25: 1–8 (1972).

    Article  Google Scholar 

  • Committee on the Review of Medicines: Recommendations on barbiturate preparations. British Medical Journal 2: 719–720 (1979).

    Article  Google Scholar 

  • Crout, J.R.: Fixed-combination prescription drugs: FDA policy; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 1–15 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Davidson, C.; Burkinshaw, L. and Morgan, D.B.: The effects of potassium supplements, spironolactone or amiloride on the potassium status of patients with heart failure. Postgraduate Medical Journal 54: 405–409 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Davies, D.L. and Wilson, G.M.: Diuretics: Mechanism of action and clinical application. Drugs 9: 178–226 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Davies, D.M., in Textbook of Adverse Drug Reactions, p.41 (Oxford University Press, Oxford 1977).

    Google Scholar 

  • Davis, F.A.: FDA regulations: Are they safe and effective for the patient? — Physicians respond; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp.28–33 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Dengler, H.J. and Lasagna, L.: Report of a workshop on fixedratio drug combinations. European Journal of Clinical Pharmacology 8: 149–154 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Desjacques, P.; Moret, P. and Gauthier, G.: Effets cardiovasculaire de la 1-dopa et de l’inhibiteur de la decarboxylase chez les malades atteints de la maladie de Parkinson. Schweizerische Medizinische Wochenschrift 103: 1783–1785 (1973).

    PubMed  CAS  Google Scholar 

  • Devadatta, S.: Isoniazid-induced encephalopathy. Lancet 2: 440 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Diamond, H.S.: Uricosuric drugs; in Kelley and Weiner (Eds) Uric Acid, pp.459–484 (Springer-Verlag, Berlin 1978).

    Chapter  Google Scholar 

  • Dollery, C.T.: Drug combinations. Prescriber’s Journal 8: 7–11 (1968).

    Google Scholar 

  • Dollery, C.T.: Pharmacological basis for combination therapy of hypertension. Annual Review of Pharmacology and Toxicology 17: 311–323 (1977).

    Article  CAS  Google Scholar 

  • Down, P.F.; Polak, A.; Rao, R. and Mead, J.A.: Fate of potassium supplements in six outpatients receiving long-term diuretics for oedematous disease. Lancet 2: 721–724 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Drug and Therapeutics Bulletin: Combinations of a diuretic with potassium. Vol. 16: 73–75 (1978).

    Google Scholar 

  • Drug and Therapeutics Bulletin: When to use oral vasodilators for hypertension. Vol. 17: 57–59 (1979a).

    Google Scholar 

  • Drug and Therapeutics Bulletin: Co-trimoxazole — too toxic for minor infections? Vol. 17: 66–68 (1979b).

    Google Scholar 

  • Drug and Therapeutics Bulletin: Action from the CRM; barbiturates. Vol. 18: 9–11 (1980a).

    Google Scholar 

  • Drug and Therapeutics Bulletin: When are drug combinations justified? Vol. 18: 37–40 (1980b).

    Google Scholar 

  • Drug and Therapeutics Bulletin: Trimethoprim in acute urinary tract infections. Vol. 18: 51–52 (1980c).

    Google Scholar 

  • Editorial: Do all pregnant women need iron? British Medical Journal 2: 1317 (1978).

  • Fairbanks, V.F. and Beutler, E.: Iron deficiency; in Williams (Ed) Hematology, 2nd ed., p.377 (McGraw Hill, New York 1977).

    Google Scholar 

  • Frewin, D.B.; Leonello, P.O. and Frewin, M.E.: Hypertension after ingestion of trimolets. Medical Journal of Australia 2: 497–498 (1978).

    PubMed  CAS  Google Scholar 

  • Gagné, J.; Biron, P. and Moisan, R.: A survey of hospital pharmacists’ knowledge of the content of drug combinations. Annals of Internal Medicine 82: 680–682 (1975).

    PubMed  Google Scholar 

  • Gandevia, B.; Hume, K.M. and Prime, F.J.: Outpatient bronchodilator therapy. Lancet 1: 956–960 (1957).

    Article  Google Scholar 

  • Garrod, L.P.; James, D.G. and Lewis, A.A.G.: The possible scope of trimethoprim-sulphonamide treatment. Postgraduate Medical Journal 45 (Suppl.): 52–55 (Nov 1969).

    PubMed  CAS  Google Scholar 

  • General Practitioners Research Group, Report No. 36: A compound ephedrine preparation for asthma. Practitioner 190: 253–257 (1963).

    Google Scholar 

  • Gibb, W.E.; Malpas, J.S.; Turner, P. and White, R.J.: Comparison of bethanidine, α-methyldopa and reserpine in essential hypertension. Lancet 2: 275–277 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt, R.B.: Oral contraceptive combinations; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 137–147 (Stratton Intercontinental Book Corporation, New York 1975).

    Google Scholar 

  • Greenwood, D. and O’Grady, F.: Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia Coli. Journal of Clinical Pathology 29: 162–166 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Gross, F.: Prescribing patterns in the Federal Republic of Germany. European Journal of Clinical Pharmacology 19: 387–396 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Healy, J.J.; McKenna, T.J.; Canning, B.St. J.; Brien, T.G.; Duffy, G.J. and Muldawney, F.P.: Body composition changes in hypertensive subjects on long-term oral diuretic therapy. British Medical Journal 1:716–719 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Helfand, W.H.: Worldwide patterns of combination drug usage. European Journal of Clinical Pharmacology 16: 221–228 (1979).

    Article  Google Scholar 

  • Hemminki, E. and Starfield, B.: Routine administration of iron and vitamins during pregnancy: Review of controlled clinical trials. British Journal of Obstetrics and Gynaecology 85: 404–410 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Horowitz, J.D.; Howes, L.G.; Christophides, N.; Lang, W.J.; Fennessy, M.R.; Rand, M.J. and Louis, W.J.: Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Lancet 1: 60–61 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Huovinen, P. and Toivanen, P.: Trimethoprim resistance in Finland after five years’ use of plain trimethoprim. British Medical Journal 280: 72–74 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Kalowski, S.; Hua, A.S.P.; Whitworth, J.A. and Kincaid-Smith, P.: Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. Medical Journal of Australia 2: 439–440 (1979).

    PubMed  CAS  Google Scholar 

  • Kaye, D.: Antibiotic combinations; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 114–121 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Kemp, B.A.: Some economic considerations of combination products — and their withdrawal; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 148–168 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Kincaid-Smith, P.: Analgesic nephropathy. Kidney International 13: 1–4 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Knight, A.H. and Parkinson, T.: Diuretic-induced hyperkalaemia. Lancet 1: 446–447 (1967).

    Article  Google Scholar 

  • Koch-Weser, J.: Medical intelligence: Drug therapy. Hydralazine. New England Journal of Medicine 295: 320–323 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Lal, S.; Bhalla, K.K. and Davey, A.J.: Slow release salbutamol and Tedral in the treatment of reversible airways obstruction. Postgraduate Medical Journal 47 (Suppl.): 89–92 (Mar 1971).

    Article  PubMed  Google Scholar 

  • Lasagna, L: The choice of a mild analgesic. Prescriber’s Journal 6: 33–37 (1966).

    Google Scholar 

  • Lasagna, L: US physicians’ use of, and opinions on, combination drugs; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp.22–27 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Lawson, D.H. and Jick, H.: Adverse reactions to co-trimoxazole in hospitalised medical patients. American Journal of the Medical Sciences 275: 53–57 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Leading Article: The antibiotic treatment of typhoid fever. Journal of Antimicrobial Chemotherapy 3: 382–383 (1977).

    Google Scholar 

  • Lee, K.Y.; Beilein, L.J. and Vandongen, R.: Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lancet 1: 1110–1111 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G.: Fixed-ratio drug combinations: Pharmacokinetic considerations; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 16–21 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Levy, G. and Procknal, J.A.: Drug biotransformation interactions in man. 1: Mutual inhibition in glucoronide formation of salicylic acid and salicylamide in man. Journal of Pharmaceutical Sciences 57: 1330–1335 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Lewis, J.G.: Adverse reactions to vitamins. Adverse Drug Reaction Bulletin 82: 296–299 (1980).

    Article  Google Scholar 

  • Lorber, S.H. and Weiner, H.I.: Gastrointestinal combination drugs; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp.73–76 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • McDevitt, D.G.: Adrenoceptor blocking drugs: Clinical pharmacology and therapeutic use. Drugs 17: 267–288 (1979).

    Article  PubMed  CAS  Google Scholar 

  • McMahon, F.G.: Drug combinations. A critique of proposed new federal regulations. Journal of the American Medical Association 216: 1008–1010 (1971).

    Article  PubMed  CAS  Google Scholar 

  • McMahon, F.G.: General arguments for and against drug combinations; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp. 8–15 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • McQueen, E.G.: New Zealand Committee on Adverse Drug Reactions: Twelfth Annual Report 1977. New Zealand Medical Journal 86: 248–250 (1977).

    PubMed  CAS  Google Scholar 

  • Marks, J.: Skin diseases; in Avery (Ed) Drug Treatment. Principles and Practice of Clinical Pharmacology and Therapeutics, 2nd ed., pp.412–449 (ADIS Press, Sydney and New York 1980).

    Google Scholar 

  • May, F.E.; Stewart, R.B. and Cluff, L.E.: Drug interactions and multiple drug administration. Clinical Pharmacology and Therapeutics 22: 322–328 (1977).

    PubMed  CAS  Google Scholar 

  • Meyers, F.H.; Jawetz, E. and Goldfien, A.: Techniques of Drug Administration in Review of Medical Pharmacology, 5th ed., p.29 (Lange Medical, California 1976).

    Google Scholar 

  • Miller, R.R; Feingold, A. and Paxinos, J.: Propoxyphene hydrochloride. A critical review. Journal of the American Medical Association 213: 996–1006 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Monthly Index of Medical Specialities (MIMS) [IMS Publishing, Artarmon, NSW, 1981].

  • Morgan, T. and Myers, J.: Diuretics. Current Therapeutics 22: 93–98 (1981).

    Google Scholar 

  • Multicenter Diuretic Co-operative Study Group: Multiclinic comparison of amiloride hydrochlorthiazide and hydrochlorthiazide plus amiloride in essential hypertension. Archives of Internal Medicine 141: 482–486 (1981).

    Article  Google Scholar 

  • Murchison, L.E.; Bewsher, P.D. and Seymour, R.: Lack of effect of bumetanide on body potassium content in hypertension. British Journal of Clinical Pharmacology 2: 87–92 (1975).

    PubMed  CAS  Google Scholar 

  • Nelson, M.M. and Forfar, J.O.: Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. British Medical Journal 1: 523–527 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Paterson, J.W. and Shenfield, G.M.: Bronchodilators, Part II. BTTA Review 9: 61–74 (1974).

    Google Scholar 

  • Paterson, J.W. and Yellin, R.H.: Combined bronchodilators in severe outpatient asthma. Current Therapeutics 19: 14–16 (1978).

    Google Scholar 

  • Penfold, D. and Volans, G.N.: Overdose from Lomotil. British Medical Journal 2: 1401–1402 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Pinder, R.M.; Brogden, R.N.; Sawyer, P.R.; Speight, T.M. and Avery, G.S.: Levodopa and decarboxylase inhibitors: A review of their clinical pharmacology and use in the treatment of Parkinsonism. Drugs 11: 329–377 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Porter, A.M.W.: Drug defaulting in a general practice. British Medical Journal 1: 218–222 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Prescott, L.F.: Analgesic nephropathy: A reassessment of the role of phenacetin and other analgesics. Drugs 23: 75–149 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Ramsay, L.E.; Boyle, P. and Ramsay, M.N.: Factors influencing serum potassium in treated hypertension. Quarterly Journal of Medicine 46: 401–410 (1977).

    PubMed  CAS  Google Scholar 

  • Schwartz, A.B. and Schwartz, C.D.: Dosage of potassium chloride elixir to convert thiazide-induced hypokalaemia. Journal of the American Medical Association 230: 702–704 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Seddon, R.J.: Hormonal steroid contraceptives: Physiological and clinical pharmacological considerations. Drugs 1: 399–420 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Shand, D.G.: Pharmacokinetic properties of the β-adrenergic receptor blocking drugs. Drugs 7: 39–47 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Shenfield, G.M.; Jones, A.N. and Paterson, J.W.: Effect of restrictions on prescribing patterns for dextropropoxyphene. British Medical Journal 281: 651–653 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Simpson, F.O.: Combination therapy in hypertension. Current Therapeutics 21: 25–33 (1980).

    Google Scholar 

  • Smith, J.W.; Seidl, L.G. and Cluff, L.E.: Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Annals of Internal Medicine 65: 629–640 (1966).

    PubMed  CAS  Google Scholar 

  • Sneddon, I.B.: Clinical use of topical corticosteroids. Drugs 11: 193–199 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Sterling, G.M.: Today’s treatment of pulmonary tuberculosis. Prescriber’s Journal 20: 8–14 (1980).

    Google Scholar 

  • Sulzberger, M.B.: Combination drug preparations in dermatology. Skin and Allergy News 3, Nos. 10 and 11 (1972).

    Google Scholar 

  • Vale, J.A.; Volans, G.N.; Crome, P. and Widdop, B.: Dextropropoxyphene poisoning. British Medical Journal 2: 424 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Van Scott, E.J.: Combination drug preparations in dermatologic therapy; in Lasagna (Ed) Combination Drugs: Their Use and Regulation, pp.110–113 (Stratton Intercontinental Medical Book Corporation, New York 1975).

    Google Scholar 

  • Vere, D.W.: Errors of complex prescribing. Lancet 1: 370–373 (1965).

    Article  PubMed  CAS  Google Scholar 

  • Waal-Manning, H.J. and Simpson, G.O.: A fixed combination of amiloride hydrochloride and hydrochlorothiazide in the treatment of hypertension: Recent studies; in Magnani (Ed) Diuresis, Kaliuresis and Hypertension, p.48 (Futura Publishing, Mt. Kisco, New York 1977).

    Google Scholar 

  • Wade, O.L. and McDevitt, G.D.: Prescribing and the British national formulary. British Medical Journal 2: 635–637 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Walker, S.R.; Evans, M.E.; Richards, A.J. and Paterson, J.W.: The clinical pharmacology of oral and inhaled salbutamol. Clinical Pharmacology and Therapeutics 13: 861–867 (1972).

    PubMed  CAS  Google Scholar 

  • Wilkinson, P.R.; Issler, H.; Hesp, R. and Raftery, E.B.: Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet 1: 759–762 (1975).

    Article  PubMed  CAS  Google Scholar 

  • World Health Organization: The selection of essential drugs. World Health Organization Technical Report Series 641 (World Health Organization, Geneva 1979).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia

    Gillian M. Shenfield

Authors
  1. Gillian M. Shenfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shenfield, G.M. Fixed Combination Drug Therapy. Drugs 23, 462–480 (1982). https://doi.org/10.2165/00003495-198223060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198223060-00003

Keywords

Search

Navigation